Dr Michael Böhm (Germany)

Dr Michael Böhm performed his medical training at the Medical School of Hannover in Germany. Residency in Internal Medicine and fellowships in Cardiology at the Ludwig Maximilians-Unversity in Munich/Germany at the Klinikum Großhadern; Heisenberg Graduate of the Deutsche Forschungsgemeinschaft; Assistant and Associate Dr of Internal Medicine and Cardiology at the Universität zu Köln in Germany.

Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. Dr Böhm's special interest includes pathophysiology and therapy of heart failure. Particular, he is involved in studies on signal transduction in the failing heart and in vascular biology. Dr Böhm has been the principal investigator in several international multicenter studies. He has written more than 350 original papers, book chapters and review articles. He has obtained several awards of scientific societies. Dr Böhm is a reviewer for most recognized scientific journals in the cardiovascular field and chief editor Clinical Research in Cardiology. He is president of the German Society of Cardiology.

Prof William Wijns (Belgium)

William Wijns, MD, PhD, FESC, is SFI Professor in Interventional Cardiology at NUI Galway since September 2016. Research efforts are targeting the development and validation of innovative techniques in interventional medicine including invasive and non-invasive physiological measurements and imaging, drug-eluting stents, and applications of multi-detector coronary CT angiography.

In addition, ongoing research aims to prevent high-risk subjects from suffering cardiac disability by modification of vulnerable plaques and modulation of trigger mechanisms that precipitate acute events.

Professor Wijns is committed to the development and evaluation of novel device-based therapies of cardiovascular diseases.

Wijns served the European Society of Cardiology (ESC) in various positions, including Vice-President, Chairman of EU Affairs, Scientific Program Chair and President of the European Association of Percutaneous Cardiac Intervention (EAPCI) of the ESC. Presently, he chairs PCR with focus on adult learning, knowledge transfer techniques and education science via Courses and other educational activities (publishing, web-based learning, seminars, and workshops).

Professor Wijns is Associate Editor of the European Heart Journal, covering acute coronary syndromes, coronary artery disease, and interventional cardiology.

Dr Nadeem Rizvi (Pakistan)

Dr Nadeem Rizvi is one of the top cardiologists in Pakistan. Aside from being highly qualified, the sheer volume of his work has earned him a reputation as one of the best interventional cardiologists. To date he has done more than 15,000 diagnostic cardiac catheterization procedures and 5,000 coronary interventions, over 100 Percutaneous Transvenous Mitral Commissurotomies, 150 peripheral interventions and 100 permanent pacemaker insertions.

He is certified in CT angiography (to visualize arterial and venous vessels throughout the body) from Johns Hopkins University Hospital, Baltimore, in Nuclear Cardiology from NICVD, in Coronary Angioplasty or the Percutaneous Transluminal Coronary Angioplasty (PTCA), a minimally invasive procedure to open up blocked coronary arteries, and the adult echocardiography from the British Society of Echocardiography. Part of his specialist training is in nuclear cardiology, electrophysiology, valvular, congenital and coronary interventions.

Dr Nadeem Rizvi has worked in the UK and in Pakistan. He was a clinical research fellow in cardiology and honorary registrar at Ealing and Hammersmith Hospitals Trusts, London. He was involved in a large research project titled, “Premature coronary arterial disease in British Asians” at Ealing Hospital. He has worked as a consultant cardiologist at Barnsley District Hospital, and he trained at the East Cheshire Hospitals Trust, Macclesfield, UK in non-invasive and invasive (pacemaker implantation and right heart studies) implantation, cardiac biopsies and interventional coronary procedures.

He is a member of the British Society of Echocardiography, a founding member of the Pakistan Society of interventional Cardiology, a member of the Pakistan Cardiac Society, a member of the Civil Aviation Medical Board and an examiner for the College of Physicians and Surgeons of Pakistan. He has been the editor of the Pakistan Heart Journal’s interventional section since 2012. He has taught, lectured and been an examiner for post-graduate trainees and residents. He has supervised the non-invasive cardiac lab (ECG, ETT, Holter, Transthoracic and Trans-esophageal echocardiography).

Dr Andrew Chapman (Scotland)

Andrew Chapman is a Cardiologist training in Scotland and an Honorary Clinical Research Fellow at the University of Edinburgh.

He recently completed a three year PhD fellowship funded by the British Heart Foundation into the use of high-sensitivity cardiac troponin for risk stratification in patients with the suspected acute coronary syndrome. His research has been published extensively and has been recognized by national and international awards, including the Samuel A. Levine Young Investigator Award by the American Heart Association in 2017.

Working with Professor Nicholas Mills and Professor David Newby, Andrew helped to deliver the High-STEACS randomized controlled trial, evaluating the implementation of a high-sensitivity cardiac troponin assay in 50,000 consecutive patients in Scotland, which will be presented as a Late-Breaking Clinical Trial at the European Society of Cardiology Congress in Munich later this year. He is leading a further randomized trial evaluating the use of an early rule out the pathway in 30,000 Emergency Department patients with the suspected acute coronary syndrome, which is due to report in early 2019.

Andrew’s main research interests are into the mechanisms of myocardial injury in patients with type 2 myocardial infarction, and he is leading a clinical trial addressing this question using both invasive and non-invasive imaging. When he has completed his training, Andrew hopes to work as an academic cardiologist in Scotland.

Dr Carlos A Mestres (Switzerland)

Dr Carlos A. Mestres, is currently a Senior Consultant in the Department of Cardiovascular Surgery, University Hospital Zürich, Zürich (Switzerland) and has expertise in Cardiovascular and Thoracic Surgery. He received his MD in 1979 and PhD in 1988 from the University of Barcelona. He holds the Spanish Certificates in Thoracic Surgery (1982) and Cardiovascular Surgery (1988), The European Board of Thoracic, and Cardiovascular Surgery (FETCS – 1988).

He has a particular interest in inflammatory/infectious cardiovascular diseases, in addition to the regular practice in all areas of surgery (especially endocarditis and HIV-1 infection), cardiovascular tissues (homograft valve and arteries), coronary surgery, valve surgery and surgery of the aorta, biomaterials and medical devices. In addition, he has a particular interest in hospital management, databases, and quality assurance. He is active in clinical surgery.

A member of the University Hospital Zürich Endokarditis Board and the Hospital Clinic Endocarditis Working Group, the latter the pioneer in co-operative work in the field in Spain and Europe, active for over three decades, a number of studies and publications were produced over the years. Dr. Mestres has participated in the development of Cardiovascular Tissue banking in Spain, as the tissue bank at the Hospital Clinic was the first of its kind in the country and a pioneer in Europe. Currently, Dr Mestres has over 260 international publications in peer-reviewed international journals, 115 domestic publications in Spanish journals and over 30 chapters in books.

Dr Mestres is a clinical surgeon. He has participated in the teaching of surgical residents in cardiovascular surgery and has experience in academic and scientific activities. He was a member of the Spanish National Cardiovascular Council, the regulatory body for Specialty training, for ten years (1997-2006). He is currently a member of the European Board of Thoracic and Cardiovascular Surgeons (EBTCS).

He serves in the Editorial Board of several Journals: Past Editor-in-Chief, Cirugia Cardiovascular,  Official Journal of the Spanish Society for Thoracic-Cardiovascular Surgery (SECTCV) 2004-2012, Associate Editor The European Journal of Cardio-Thoracic Surgery (2012-2017), Associate Editor - Asian Cardiovascular and Thoracic Annals (2005).  He also serves as an  Editorial Board Member - The Journal of Thoracic and Cardiovascular Surgery (2013-2020), The European Journal of Cardio-thoracic Surgery (EJCTS)

 Dr Mestres is currently the Director of the Teaching Programme of the CAS-Certificate of Advanced Studies in Structural Cardiac Interventions (www.structuralinterventions.ch) issued by the University of Zürich.

Graeme Codrington (South Africa)

Graeme Codrington is an expert on the future of work. He is a researcher, author, futurist, presenter and board advisor working across multiple industries and sectors. He has a particular interest in disruptive forces changing how people live, work, interact and connect with each other.

Speaking internationally to over 100,000 people in more than 20 different countries every year, his client list includes some of the world’s top companies, and CEOs invite him back time after time to share his latest insights and help them and their teams gain a clear understanding of how to successfully prepare for the future. Graeme is the co-founder and international director of TomorrowToday, a global firm of futurists and business strategists. He is also a guest lecturer at five top business schools, including the London Business School, Duke Corporate Education and the Gordon Institute of Business Science. He has five degrees, including a Doctorate in Business Administration (DBA), a Masters in Sociology, and other professional degrees in Accounting, Arts and Theology, and Youth Work.

Graeme is the only speaker in the world to have been admitted to two different speakers halls of fame, in both South Africa and the UK (where he was awarded the Professional Speaking Association’s Award of Excellence). He is one of only a handful of professional speakers in the world to have earned the Global Certified Speaking Professional status from the Global Speakers Federation.

He has written five books, including the award winning, “Mind the Gap” and “Future-Proof Your Child”, published by Penguin. His latest book is “Leading in a Changing World”, published in July 2015. Graeme writes regularly for numerous blogs, magazines and journals, and is regularly called upon for comment by the media around the world.

Graeme’s breadth of knowledge and expertise make him highly relevant in today’s rapidly evolving business world. Along with his formal qualifications and research credentials, he has a wide range of business experience. He did Chartered Accountancy articles at KPMG, was involved in an IT startup, worked in the Charity sector, has been a professional musician, a strategy consultant and is now a full-time speaker, facilitator and author.


Professor Ian Graham (Ireland)

Ian Graham is Professor of Cardiovascular Medicine in Trinity College, Dublin, and Professor Emeritus of Preventive Cardiology at the Royal College of Surgeons in Ireland. He is Secretary-Treasurer and Board Member of the European Society of Cardiology and Chairman of the Adelaide Health Foundation Health Policy Initiative. He is a member of the 6th Joint European Societies Task Force on the Prevention of Cardiovascular Disease in clinical practice and of its Prevention Implementation Committee, having Chaired the 4th Task Force. He is co-Chair of the 2016 European Guidelines on the management of dyslipidaemias, and co-Chair of an expert group that is advising the World Health Organisation on cardiovascular risk estimation.

Professor Graham studied medicine at Trinity College in Dublin and worked in Dublin and Cambridge before becoming Head of Cardiology at Tallaght Hospital in Dublin and Vice-Chair of its Board of management. He was Director of Research at St Vincent’s Hospital in Dublin and at the Irish Heart Foundation. He is past President of the Irish Heart Foundation, the Dublin University Biological Association and the Irish Hyperlipidaemia Association. He founded the Irish National Cardiac Surgery register.

He is an honorary Fellow of Trinity College in Dublin, a Fellow of the Royal College of Physicians and a Fellow of the Royal Academy of Medicine in Ireland. He is a recipient of the Stokes Medal of the Irish Cardiac Society, and Sir Thomas and Lady Dixon Medal from the Royal Victoria Hospital in Belfast. He held a Medical Research Council Fellowship, an EU travelling Fellowship at Erasmus University in Rotterdam and an ISFC Cardiovascular Epidemiology Fellowship.

Research interests include the natural history of coronary heart disease, cardiovascular risk estimation, blood lipids, health policy and planning and the evaluation of therapies. He has written extensively in these areas.       

Professor Gil Bolotin (Israel)

Professor Bolotin received his MD in 1993 from the Hebrew University ‐ Hadassah Medical School in Jerusalem, Israel; and his PhD. in 2001 from Academic Hospital Maastricht, The Netherlands. He performed his residency in the Department of Cardio-Thoracic Surgery at Carmel Medical Center, Haifa, Israel. In 2007, he was appointed Director of the Department of Cardiac Surgery, Rambam Medical Center. In 2015, he was appointed Clinical Associate Professor at the Ruth & Bruce Rappaport Faculty of Medicine, Technion Institute of Technology (Technion), Haifa, Israel.

In addition, Professor Bolotin was the Chairman of the Israel Society of Cardiothoracic Surgery (2014-2017) and is a member of international professional cardiothoracic societies - European Society of Cardiothoracic Surgery and World Society of Cardiothoracic Surgeons.

Professor Bolotin has published over 100 publications in peer‐review journals and book chapters and presented at numerous international professional meetings. He also has extensive teaching experience in national and international cardiothoracic surgery courses.

From the onset of his medical career, Professor Bolotin was deeply interested in medical devices from engineering design through in vitro, in vivo and clinical studies. His research interests have since expanded to span the entire range of cardiothoracic surgery, with a special interest in minimally invasive valve surgery, transcatheter valve implantation, atrial fibrillation, robotic cardiac surgery and other innovations in cardiac surgery.

Professor Lars G Svensson (USA)

Lars Georg Svensson is the Chairman of the Sydell and Arnold Miller Family Heart and Vascular Institute as well as Staff Surgeon in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic. He is also Professor of Surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Svensson is board-certified in general, vascular, thoracic and cardiac surgery. He specialises in aortic valve surgery, aortic valve and bicuspid valve repair, cardiac surgery, complex aortic aneurysm, endovascular aorta treatment, heart surgery of patients with Marfan Syndrome, modified David’s reimplantation procedure, percutaneous treatment of patients with valve disease, minimally invasive heart surgery, Marfan syndrome and connective tissue disorders. He obtained his medical degree in 1978, a MSc in 1983 and a PhD in 1986 from the University of Witwatersrand, Johannesburg, South Africa. He completed his Cardiology, General and Vascular Surgery training at the Johannesburg Hospital, followed by Cardiovascular Surgery training at the Cleveland Clinic (Cleveland, Ohio), and Baylor College of Medicine (Houston, TX) including Cardiothoracic Surgery residency. He was Chief of Cardiovascular Surgery at Houston Veterans Affairs Medical Center and worked with Drs. DeBakey and Crawford at Baylor College of Medicine. He was Assistant Professor of Surgery at Baylor College of Medicine, and then Professor of Cardiothoracic Surgery at Tufts University, and Instructor at Harvard Medical School while working at the Lahey Hospital and Medical Center in Boston. In 2005 he was made King James IV Professor of Surgery of The Royal College of Surgeons of Edinburgh, Scotland. He is on numerous committees, including the Society of Thoracic Surgery, American Association for Thoracic Surgery Government Relations Committee, Annals of Thoracic Surgery, and the Cleveland Clinic Surgery Committee. His interests are minimal invasive valve surgery, percutaneous cardiovascular surgery, and brain and spinal cord protection during cardiovascular surgery.

Professor Mark Petrie (UK)

Mark Petrie is Professor of Cardiology at the University of Glasgow.  He worked as a clinician with a sub-speciality interest in heart failure, advanced heart failure and interventional cardiology before accepting a formal academic role 2 years ago.  He is also on the steering and executive committees of many trials (including intravenous iron, various interventional heart failure therapies, trials of coronary artery disease and HF (STICH and REVIVED) and others).  He was an author of the ESC NSTEMI guidelines and a senior author of the ESC Position Statement on Diabetes and Heart Failure.   He is involved in ongoing trials of diabetes therapies in cardiovascular disease and heart failure. One of his major interests is peripartum cardiomyopathy (member of the Executive Committee and Steering Group of the ESC Peripartum Cardiomyopathy Registry).  Mark is the UK Lead for PARADISE-MI and Dapa-HF and has also served on the Clinical Events Committee of over 30 trials including EMPA-REG OUTCOME, TRUE-HF, ASCEND, the original HARMONY programme, CARMELINA and CAROLINA amongst many others.